Page last updated: 2024-08-24

bromfenac and Wet Macular Degeneration

bromfenac has been researched along with Wet Macular Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gomi, F; Nishida, K; Sawa, M; Tsujikawa, M	1

Trials

1 trial(s) available for bromfenac and Wet Macular Degeneration

Article	Year
Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration. Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:9 Topics: Administration, Topical; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bromobenzenes; Double-Blind Method; Drug Therapy, Combination; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration	2012

Article

Year

Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.

Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:9

Topics: Administration, Topical; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bromobenzenes; Double-Blind Method; Drug Therapy, Combination; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration

2012